Mr. Edwin Clifton Jones is a pharmacist who is specialized in Pharmacotherapy in Jacksonville, Florida. Patients can reach him at 4297 Oldfield Crossing Dr, Jacksonville or contact him on 904-288-0652. Active license number of Mr. Edwin Clifton Jones is PS0013060 for Pharmacotherapy in Florida. Mr. Edwin Clifton Jones is a licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing pharmacotherapeutic care of patients, by developing, implementing, monitoring, and modifying complex treatment plans, providing advanced level education and consultation, and collaborating with other health professionals in the management of therapy.
Complete Profile:
Mr. Edwin Clifton Jones speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for enquiries.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of Mr. Edwin Clifton Jones are as mentioned below.
NPI Number:
1477833085
NPI Enumeration Date:
26 Aug, 2011
NPI Last Update On:
26 Aug, 2011
Medical Licenses:
Pharmacists can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Mr. Edwin Clifton Jones are as mentioned below.
Specialization
License Number
State
Status
Pharmacotherapy
PS0013060
Florida
Primary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
4297 Oldfield Crossing Dr, Jacksonville, Florida
Zip:
32223-7866
Phone Number:
904-288-0652
Fax Number:
--
Patients can reach Mr. Edwin Clifton Jones at 4297 Oldfield Crossing Dr, Jacksonville, Florida or can call on phone at 904-288-0652.
Comments/ Reviews:
*Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 14 October, 2024.